Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK appoints stem cell bank operator:

This article was originally published in Clinica

Executive Summary

The National Institute for Biological Standards and Control has been appointed to set up the UK stem cell bank, the Medical Research Council (MRC) announced today (September 9 2002). The £2.6m ($4m) contract for the project will be managed by the MRC, which will share 75% of the costs with the Biotechnology and Biological Sciences Research Council (25%). The creation of the stem cell bank was one of 27 recommendations of a House of Lords committee set up to assess how best to regulate the technology. Its report was published at the end of February 2002, when the Lords gave qualified support for work in this area to go ahead under current legislation (see Clinica No 998, p 6). The Medical Devices Agency is represented on an MRC committee set up to develop principles and practices regarding the ethical, legal and regulatory issues associated with stem cell banking and research.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel